Group 1 - The core viewpoint is that the Hong Kong stock market has shown strong attractiveness in 2025, driven by policy support and the AI boom, outperforming key markets like the US and Japan year-to-date [1] - The AI narrative initiated by DeepSeek has significantly propelled the revaluation of Chinese assets, with Hong Kong stocks leading globally at the beginning of the year. Although the AI enthusiasm has slightly cooled due to geopolitical factors, future iterations of AI models or breakthroughs in applications could reignite upward catalysts for the sector [1][2] - As of June 12, 2025, southbound capital has net purchased HK stocks amounting to 681.14 billion HKD, reaching 84.3% of the total net purchase for the entire year of 2024 (807.87 billion HKD). This influx is driven by the demand for stable returns from dividends and structural opportunities in new consumption, AI technology, and innovative pharmaceuticals [1] Group 2 - The attractiveness of Hong Kong stocks is further enhanced by their long-term valuation being relatively low. As of June 16, 2025, the Hang Seng Tech Index's latest PE (TTM) is only 20.18 times, which is at the 9.02% valuation percentile over the past five years, indicating that the current valuation is lower than 90% of the time in the last five years [2] - With the recovery of the domestic economy, expectations for AI performance catalysts, and more quality companies listing in Hong Kong, there is potential for valuation uplift in the second half of the year [2] - Relevant ETFs include the Hang Seng Internet ETF (513330), Hang Seng Pharmaceutical ETF (159892), and Hang Seng Technology Index ETF (513180) [2]